{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T19:26:35Z","timestamp":1761765995012},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1016\/j.jpba.2015.10.017","type":"journal-article","created":{"date-parts":[[2015,10,25]],"date-time":"2015-10-25T15:18:11Z","timestamp":1445786291000},"page":"64-69","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["UHPLC\u2013MS\/MS method with automated on-line solid phase extraction for the quantification of entecavir in peripheral blood mononuclear cells of HBV+ patients"],"prefix":"10.1016","volume":"118","author":[{"given":"Amedeo","family":"De Nicol\u00f2","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriele","family":"Bonifacio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucio","family":"Boglione","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica","family":"Cusato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Debora","family":"Pensi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Tomasello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Di Perri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"D'Avolio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2015.10.017_bib0005","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jhep.2012.02.010","article-title":"Clinical Practice Guidelines: management of chronic hepatitis B virus infection","volume":"57","author":"EASL","year":"2012","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jpba.2015.10.017_bib0010","doi-asserted-by":"crossref","first-page":"3992","DOI":"10.1128\/JVI.02395-06","article-title":"Inhibition of hepatitis B virus polymerase by entecavir","volume":"81","author":"Langley","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.jpba.2015.10.017_bib0015","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1186\/1471-2334-11-178","article-title":"Unsuccessful therapy with adefovir and entecavir tenofovir in a patient with chronic hepatitis B infection with previous resistance to lamivudine: a fourteen-year evolution of hepatitis B virus mutations","volume":"11","author":"Benetti","year":"2011","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.jpba.2015.10.017_bib0020","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.2165\/00003495-200969080-00005","article-title":"Entecavir: a review of its use in chronic hepatitis B","volume":"69","author":"Scott","year":"2009","journal-title":"Drugs"},{"key":"10.1016\/j.jpba.2015.10.017_bib0025","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1111\/jvh.12018","article-title":"Sequential therapy with entecavir and PEG-INF in patients affected by chronic hepatitis B and high levels of HBV-DNA with non-D genotypes","volume":"20","author":"Boglione","year":"2013","journal-title":"J. Viral Hepat."},{"issue":"11","key":"10.1016\/j.jpba.2015.10.017_bib0030","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1016\/j.cgh.2015.06.002","article-title":"Association between level of hepatitis B surface antigen and relapse after entecavir therapy for chronic HBV infection","volume":"13","author":"Chen","year":"2015","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.jpba.2015.10.017_bib0035","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1136\/gutjnl-2014-307237","article-title":"Treatment cessation of entecavir in Asian patients with hepatitis B e antigen negative chronic hepatitis B: a multicentre prospective study","volume":"64","author":"Seto","year":"2014","journal-title":"Gut"},{"key":"10.1016\/j.jpba.2015.10.017_bib0040","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jpba.2015.05.016","article-title":"UPLC\u2013MS\/MS method for the simultaneous quantification of anti-HBV nucleos(t) ides analogs: entecavir, lamivudine, telbivudine and tenofovir in plasma of HBV infected patients","volume":"114","author":"De Nicol\u00f2","year":"2015","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2015.10.017_bib0045","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.jchromb.2011.02.023","article-title":"LC-ESI\u2013MS\/MS method for the quantification of entecavir in human plasma and its application to bioequivalence study","volume":"879","author":"Challa","year":"2011","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jpba.2015.10.017_bib0050","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/j.jpba.2009.02.003","article-title":"A sensitive method for the determination of entecavir at picogram per milliliter level in human plasma by solid phase extraction and high-pH LC\u2013MS\/MS","volume":"49","author":"Zhang","year":"2009","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2015.10.017_bib0055","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jchromb.2011.12.003","article-title":"Salting-out homogeneous liquid\u2013liquid extraction approach applied in sample pre-processing for the quantitative determination of entecavir in human plasma by LC\u2013MS","volume":"881\u2013882","author":"Zhao","year":"2012","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jpba.2015.10.017_bib0060","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ejps.2015.02.010","article-title":"Decreased liver distribution of entecavir is related to down-regulation of Oat2\/Oct1 and up-regulation of Mrp1\/2\/3\/5 in rat liver fibrosis","volume":"71","author":"Xu","year":"2015","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jpba.2015.10.017_bib0065","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.ejps.2012.12.024","article-title":"OAT1 and OAT3: targets of drug?drug interaction between entecavir and JBP485","volume":"48","author":"Xu","year":"2013","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jpba.2015.10.017_bib0070","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ejps.2013.10.010","article-title":"The oligopeptide transporter 2-mediated reabsorption of entecavir in rat kidney","volume":"52","author":"Xu","year":"2013","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jpba.2015.10.017_bib0075","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jpba.2013.11.027","article-title":"Development and validation of a useful UPLC\u2013MS\/MS method for quantification of total and phosphorylated-ribavirin in peripheral blood mononuclear cells of HCV+ patients","volume":"90","author":"Agnesod","year":"2013","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2015.10.017_bib0080","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.jpba.2014.05.040","article-title":"UPLC\u2013MS\/MS method for quantification of the azathioprine metabolites 6-mercaptoguanosine and 6-methylmercaptopurine riboside in peripheral blood mononuclear cells","volume":"98","author":"De Nicol\u00f2","year":"2014","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2015.10.017_bib0085","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.jpba.2015.08.004","article-title":"UPLC\u2013MS\/MS method with automated on-line SPE for the isomer-specific quantification of the first-generation anti-HCV protease inhibitors in peripheral blood mononuclear cells","volume":"115","author":"De Nicol\u00f2","year":"2015","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2015.10.017_bib0090","unstructured":"FDA, Guidance for Industry Bioanalytical Method Validation, 2013."},{"key":"10.1016\/j.jpba.2015.10.017_bib0095","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.jpba.2015.01.054","article-title":"An UPLC\u2013MS\/MS method coupled with automated on-line SPE for quantification of tacrolimus in peripheral blood mononuclear cells","volume":"107","author":"Pensi","year":"2015","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2015.10.017_bib0100","doi-asserted-by":"crossref","first-page":"2976","DOI":"10.1128\/AAC.01236-10","article-title":"Evaluation of the mean corpuscular volume of peripheral blood mononuclear cells of HIV patients by a coulter counter to determine intracellular drug concentrations","volume":"55","author":"Simiele","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jpba.2015.10.017_bib0105","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.clinbiochem.2004.11.007","article-title":"Matrix effects: the Achilles heel of quantitative high-performance liquid chromatography\u2013electrospray-tandem mass spectrometry","volume":"38","author":"Taylor","year":"2005","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.jpba.2015.10.017_bib0110","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.jpba.2012.03.030","article-title":"Development and validation of a useful HPLC-UV method for quantification of total and phosphorylated-ribavirin in blood and erythrocytes of HCV+ patients","volume":"66","author":"D'Avolio","year":"2012","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2015.10.017_bib0115","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.1128\/AAC.43.11.2716","article-title":"High-performance liquid chromatographic determination of ribavirin in whole blood to assess disposition in erythrocytes","volume":"43","author":"Homma","year":"1999","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jpba.2015.10.017_bib0120","doi-asserted-by":"crossref","first-page":"3813","DOI":"10.1128\/AAC.48.10.3813-3816.2004","article-title":"Liquid chromatography assay for routine monitoring of cellular ribavirin levels in blood","volume":"48","author":"Inoue","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jpba.2015.10.017_bib0125","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.jchromb.2005.02.010","article-title":"Intracellular measurements of anti-HIV drugs indinavir, amprenavir, saquinavir, ritonavir, nelfinavir, lopinavir, atazanavir, efavirenz and nevirapine in peripheral blood mononuclear cells by liquid chromatography coupled to tandem mass spectrometry","volume":"819","author":"Colombo","year":"2005","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jpba.2015.10.017_bib0130","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1128\/AAC.48.7.2388-2393.2004","article-title":"Intracellular and plasma pharmacokinetics of saquinavir-ritonavir, administered at 1600\/100 milligrams once daily in human immunodeficiency virus-infected patients","volume":"48","author":"Ford","year":"2004","journal-title":"Antimicrob. Agents Chemother."}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708515301904?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708515301904?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,31]],"date-time":"2019-08-31T23:08:33Z","timestamp":1567292913000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708515301904"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":26,"alternative-id":["S0731708515301904"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2015.10.017","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2016,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"UHPLC\u2013MS\/MS method with automated on-line solid phase extraction for the quantification of entecavir in peripheral blood mononuclear cells of HBV+ patients","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2015.10.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}